as 07-11-2025 2:27pm EST
Stocks
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Founded: | 2016 | Country: | United States |
Employees: | 1000 | City: | MENLO PARK |
Market Cap: | 1.6B | IPO Year: | N/A |
Target Price: | $31.50 | AVG Volume (30 days): | 1.3M |
Analyst Decision: | Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -58.52 | EPS Growth: | N/A |
52 Week Low/High: | $12.33 - $63.99 | Next Earning Date: | 08-12-2025 |
Revenue: | $130,711,000 | Revenue Growth: | 30.47% |
Revenue Growth (this year): | 19.52% | Revenue Growth (next year): | 20.37% |
GRAL Breaking Stock News: Dive into GRAL Ticker-Specific Updates for Smart Investing
Simply Wall St.
17 days ago
Medical Device Network
23 days ago
MT Newswires
24 days ago
PR Newswire
24 days ago
Yahoo Finance Video
a month ago
Yahoo Finance
a month ago
CNW Group
a month ago
PR Newswire
a month ago
The information presented on this page, "GRAL GRAIL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.